| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.45 | 0.06 |